Daiichi Sankyo nabs Japanese approval for Tarlige tablets in neuropathic pain
29 Mar 2022 //
PHARMABIZ
Menarini to commercialize Japanese drug in Singapore, Malaysia, and Philippines
23 Aug 2021 //
BIOSPECTRUM ASIA
Daiichi Sankyo Announces Phase 3 Study Results of mirogabalin
18 Dec 2020 //
DAIICHISANKYO
Daiichi Sankyo Announces Ph 3 Study Results of mirogabalin
18 Dec 2020 //
RUTERS
Daiichi Sankyo starts mirogabalin trial in spinal injury pain
28 Mar 2019 //
PMLIVE